Phase I Clinical Trial of Temsirolimus and Perifosine for Recurrent Glioblastoma

Annals of Clinical and Translational Neurology - United States
doi 10.1002/acn3.51009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2015English

Autologous HER2 CMV Bispecific CAR T Cells Are Safe and Demonstrate Clinical Benefit for Glioblastoma in a Phase I Trial.

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

A Phase I Trial of Temsirolimus and Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer

Chemotherapy
MedicineDrug DiscoveryInfectious DiseasesOncologyPharmacology
2016English

Gene Therapy for Pain: Results of a Phase I Clinical Trial

Annals of Neurology
Neurology
2011English

A Phase I Trial of Enzastaurin in Patients With Recurrent Gliomas

Clinical Cancer Research
Cancer ResearchOncology
2009English

Phase I Clinical Trial Combining Imatinib Mesylate and IL-2

OncoImmunology
OncologyAllergyImmunology
2013English

Multicenter Phase II Trial of Temsirolimus (TEM) and Bevacizumab (BEV) in Pancreatic Neuroendocrine Tumor (PNET).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Phase I Clinical Trial of a Peptide Vaccine Combined With Tegafur-Uracil Plus Leucovorin for Treatment of Advanced or Recurrent Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2013English

A Randomised Phase II Trial of Selumetinib vs Selumetinib Plus Temsirolimus for Soft-Tissue Sarcomas

British Journal of Cancer
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy